Filtered By:
Therapy: Hyperbaric Oxygen Therapy
Nutrition: Vitamin A

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Current treatment of central retinal artery occlusion: a national survey
ConclusionsThis survey shows that there is significant variability in treatment practices for acute CRAO in the US. Because of the high cerebrovascular and cardiovascular risk reported in this population of patients, it is notable that the approach to risk factor screening is also highly variable and many programs do not routinely refer patients to an emergency department for urgent evaluation. Finally, there appears to be equipoise among treatment teams regarding the efficacy of systemic fibrinolysis, as 53% of programs report a willingness to treat at least some patients with this modality.
Source: Journal of Neurology - December 13, 2017 Category: Neurology Source Type: research

Management of central retinal artery occlusion following successful hyperbaric oxygen therapy: case report.
Conclusion: Recovery of vision during initial HBO₂ treatment indicated that this patient's retina had not yet suffered irreversible ischemic damage at that point in time. CRAO patients with a good result from initial HBO₂ treatment should be admitted to a stroke center and should have their visual status monitored hourly. Should vision loss recur, aggressive use of intermittent 100% normobaric and hyperbaric oxygen is indicated to preserve retinal function until central retinal artery recanalization occurs. An evidence-based management plan for such patients is presented. PMID: 29571239 [PubMed - in process]
Source: Undersea and Hyperbaric Medicine - January 1, 2018 Category: Sports Medicine Authors: Butler FK, Hagan C, Van Hoesen K, Murphy-Lavoie H Tags: Undersea Hyperb Med Source Type: research

The Hyperbaric Oxygen Therapy Protocol in Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution
We read with interest the research article entitled “Acute Central Retinal Artery Occlusion Seen within 24 h at a Tertiary Institution”,1 it was an original study focusing on the timing of emergency hospital attendance after acute Central Retinal Artery Occlusion (CRAO) onset from sudden vision loss. The authors were particularly concerned on th e CRAO protocol of intravenous thrombolysis and diagnostic pathway. However, as the Hyperbaric Oxygen Therapy (HBOT) practitioners running the HORA study,2–5 we are more interested in the HBOT protocol adopted in the authors’ tertiary institution, which was not mentioned in the article.
Source: Journal of Stroke and Cerebrovascular Diseases - August 13, 2021 Category: Neurology Authors: Sunny Chi Lik Au Tags: Letter to the Editor Source Type: research